WGSWW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)0.0% YoY
Profit margin-4.9%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-7.6%
Operating margin
-10.6%
Revenue growth YoY
26.5%
Dividend yield
Beta
2.19

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About GeneDx Holdings Corp.

GeneDx Holdings Corp. (Ticker: WGSWW) is a leader in the genomics sector, specializing in genomic testing and precision medicine aimed at diagnosing rare and undiagnosed genetic conditions. Utilizing cutting-edge sequencing technologies and an extensive database of genetic knowledge, GeneDx equips healthcare providers with essential diagnostic tools that inform treatment strategies. The company’s diverse portfolio of genetic testing services and its strategic partnerships within the healthcare ecosystem position it favorably in an increasingly competitive market, underscoring its commitment…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
NORTH TOWER, STAMFORD, CT
Fiscal year end
December
Latest quarter
Dec 31, 2025
Shares outstanding$0
52W high$0.13
52W low$0.00

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer